VIRALEZE launch in ADMENTA Italia Group pharmacies in Italy
Filed with ASX · · 3 pages · English
Starpharma Holdings Limited on 6ix
Earlier from Starpharma
- VIRALEZE Protects Against SARS-CoV-2 in Challenge Model
- VIRALEZE well tolerated in multiple dose clinical study
- VIRALEZE SPL7013 virucidal against SARS-CoV-2 Delta variant
- VIRALEZE UK Update
- VIRALEZE SPL7013 virucidal against multiple COVID variants
Later from Starpharma
- VIRALEZE distribution and supply to Vietnam
- Positive DEP phase 2 interim results in prostate cancer
- AGM Chairman address and CEO presentation
- VIRALEZE registered in Vietnam with launch this week
- VIRALEZE distribution agreement and launch in Vietnam
Follow Starpharma into a list and get an email when it puts out news.
Follow Starpharma